Menopausal status: An important consideration in determining the biology and prognosis of estrogen receptor-positive and progesterone receptor-negative breast cancer

被引：0
|
作者：
Fujisue, M.
Nishimura, R.
Nakano, M.
Tashima, R.
Nishiyama, Y.
Osako, T.
Toyozumi, Y.
Arima, N.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-05-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-05-06
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients
    Bal, Oznur
    Arslan, Ulku Yalcintas
    Durnali, Ayse
    Uyetrk, Ummugul
    Demirci, Ayse
    Tastekin, Didem
    Ekinci, Ahmet
    Esbah, Onur
    Turker, Ibrahim
    Sonmez, Ozlem Uysal
    Oksuzoglu, Berna
    JOURNAL OF BUON, 2015, 20 (01): : 28 - 34
  • [32] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    Niemeier, Leo A.
    Dabbs, David J.
    Beriwal, Sushil
    Striebel, Joan M.
    Bhargava, Rohit
    MODERN PATHOLOGY, 2010, 23 (02) : 205 - 212
  • [33] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2014, 27 : 76A - 76A
  • [34] Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
    Liu, Xi-Yu
    Ma, Ding
    Xu, Xiao-En
    Jin, Xi
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    THERANOSTICS, 2018, 8 (22): : 6386 - 6399
  • [35] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    LABORATORY INVESTIGATION, 2014, 94 : 76A - 76A
  • [36] Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
    Farhat, Ghada N.
    Cummings, Steven R.
    Chlebowski, Rowan T.
    Parimi, Neeta
    Cauley, Jane A.
    Rohan, Thomas E.
    Huang, Alison J.
    Vitolins, Mara
    Hubbell, F. Allan
    Manson, JoAnn E.
    Cochrane, Barbara B.
    Lane, Dorothy S.
    Lee, Jennifer S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 562 - 570
  • [37] Estrogen receptor positive but progesterone receptor negative breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01)
  • [38] Estrogen receptor α-negative and progesterone receptor-positive breast cancer:: Lab error or real entity?
    Kiani, Jawad
    Khan, Afrasyab
    Khawar, Hina
    Shuaib, Fawad
    Pervez, Shahid
    PATHOLOGY & ONCOLOGY RESEARCH, 2006, 12 (04) : 223 - 227
  • [39] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
    Young, Amy
    Guan, Jane
    Daemen, Anneleen
    Friedman, Lori
    Lin, Kui
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
  • [40] A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer
    Fan, Yu
    Zhong, Xiaorong
    Wang, Yu
    Wang, Zhu
    Luo, Ting
    Wang, Yanping
    Zheng, Hong
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (02) : 171 - 182
12345